ArticleGenes2022

Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy.

Marianna Maretina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.